PCNA and acute lymphoblastic leukemia: Since the in vitro results were in agreement with the clinicopathological features and low expression of PCNA_V2 and PCNA_V4 was observed in relapsed patients, our results suggest that these transcript variants are potential molecular markers of relapse in acute lymphoblastic leukemia patients.